e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Screening for lung cancer - Opportunities and challenges
Georgia Hardavella (Athens, Greece)
Source:
Short video statement 2020
Number:
3
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Georgia Hardavella (Athens, Greece). Screening for lung cancer - Opportunities and challenges. Short video statement 2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Ioannis Karampinis - 28.10.2020 11:00
Well delivered information, to the point! It provides an excellent overview of the current evidence, opportunities and challenges of lung cancer screening.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Lung cancer screening - where we are and how to implement it
Source: International Congress 2018 – ME5 Lung cancer screening
Year: 2018
Novel survey tool used to assess priorities of lung cancer patients and carers
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Screening for lung cancer
Source: International Congress 2017 – Lung cancer for the pulmonologist
Year: 2017
Biomarkers in early-detection of lung cancer: current concepts
Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts
Year: 2021
Population’s understanding and degree of participation of a screening lung cancer programme
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015
Milestones in the management of lung cancer
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009
Challenges of evaluating lung function as part of cancer care during the COVID-19 pandemic
Source: Eur Respir J, 56 (2) 2001621; 10.1183/13993003.01621-2020
Year: 2020
Computed tomographic screening for lung cancer: individualising the benefit of the screening
Source: Eur Respir J 2007; 30: 843-847
Year: 2007
Delay in diagnosis and management of lung cancer in developing countries
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016
Management of lung cancer screening and incidental findings as well as their integration in existing lung cancer care
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019
Therapeutic management of non-small cell lung cancers in Tunisia
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013
Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect
Source: ISSN=ISSN 1810-6838, ISBN=, page=339
Year: 2006
Metabolic modification as a potential therapeutics approach in lung cancer
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept